Novo Nordisk A/S (ETR:NOV)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of EUR 173.33 billion. The enterprise value is 182.52 billion.

Market Cap	173.33B
Enterprise Value	182.52B

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	3.37B
Shares Outstanding	n/a
Shares Change (YoY)	-0.46%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	29.57%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 12.47 and the forward PE ratio is 11.67.

PE Ratio	12.47
Forward PE	11.67
PS Ratio	4.10
PB Ratio	7.62
P/TBV Ratio	20.45
P/FCF Ratio	19.62
P/OCF Ratio	10.46
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.41, with an EV/FCF ratio of 20.66.

EV / Earnings	13.14
EV / Sales	4.32
EV / EBITDA	8.41
EV / EBIT	9.17
EV / FCF	20.66

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.60.

Current Ratio	0.78
Quick Ratio	0.53
Debt / Equity	0.60
Debt / EBITDA	0.62
Debt / FCF	1.53
Interest Coverage	18.58

Financial Efficiency

Return on equity (ROE) is 71.46% and return on invested capital (ROIC) is 41.42%.

Return on Equity (ROE)	71.46%
Return on Assets (ROA)	20.43%
Return on Invested Capital (ROIC)	41.42%
Return on Capital Employed (ROCE)	53.49%
Revenue Per Employee	537,940
Profits Per Employee	176,879
Employee Count	77,349
Asset Turnover	0.69
Inventory Turnover	1.30

Taxes

In the past 12 months, Novo Nordisk has paid 3.77 billion in taxes.

Income Tax	3.77B
Effective Tax Rate	21.33%

Stock Price Statistics

The stock price has decreased by -59.49% in the last 52 weeks. The beta is 0.33, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-59.49%
50-Day Moving Average	47.44
200-Day Moving Average	58.95
Relative Strength Index (RSI)	19.70
Average Volume (20 Days)	405,705

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of EUR 42.26 billion and earned 13.89 billion in profits. Earnings per share was 3.12.

Revenue	42.26B
Gross Profit	34.80B
Operating Income	19.90B
Pretax Income	17.66B
Net Income	13.89B
EBITDA	21.49B
EBIT	19.90B
Earnings Per Share (EPS)	3.12

Balance Sheet

The company has 4.36 billion in cash and 13.55 billion in debt, giving a net cash position of -9.19 billion.

Cash & Cash Equivalents	4.36B
Total Debt	13.55B
Net Cash	-9.19B
Net Cash Per Share	n/a
Equity (Book Value)	22.75B
Book Value Per Share	5.12
Working Capital	-7.03B

Cash Flow

In the last 12 months, operating cash flow was 16.57 billion and capital expenditures -7.74 billion, giving a free cash flow of 8.83 billion.

Operating Cash Flow	16.57B
Capital Expenditures	-7.74B
Free Cash Flow	8.83B
FCF Per Share	n/a

Margins

Gross margin is 82.35%, with operating and profit margins of 47.10% and 32.88%.

Gross Margin	82.35%
Operating Margin	47.10%
Pretax Margin	41.80%
Profit Margin	32.88%
EBITDA Margin	50.85%
EBIT Margin	47.10%
FCF Margin	20.90%

Dividends & Yields

This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 3.94%.

Dividend Per Share	1.56
Dividend Yield	3.94%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	5
Payout Ratio	49.88%
Buyback Yield	0.46%
Shareholder Yield	4.39%
Earnings Yield	8.02%
FCF Yield	5.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 6.13 and a Piotroski F-Score of 4.

Altman Z-Score	6.13
Piotroski F-Score	4